Related Experiment Video

Updated: Aug 10, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein

S Ahmad1, Y M Alsayed, B J Druker

  • 1Section of Hematology-Oncology, University of Illinois at Chicago and West Side Veterans Administration Hospital, Chicago, Illinois 60607, USA.

The Journal of Biological Chemistry
|December 31, 1997
PubMed

Insights

Interferon (IFN) alpha rapidly phosphorylates the CrkL protein, a key signaling molecule. This process, mediated by Tyk-2 kinase, links interferon signaling to tumor suppressor pathways, inhibiting cell growth.

Area of Science:

  • Cellular signaling
  • Immunology
  • Molecular biology

Background:

  • Interferons (IFNs) are crucial cytokines in the immune response.
  • CrkL is an adaptor protein involved in various cellular processes.
  • Type I IFNs signal through the Type I Interferon Receptor (IFNR).

Purpose of the Study:

  • To investigate the role of CrkL in Type I IFN signaling.
  • To identify the kinases involved in IFN-induced CrkL phosphorylation.
  • To elucidate the downstream signaling cascade initiated by CrkL phosphorylation.

Main Methods:

  • Immunoprecipitation to detect protein-protein interactions and kinase activity.
  • Western blotting to assess protein phosphorylation.
  • Cell culture of IFN-sensitive cell lines (U-266, Daudi).

Main Results:

  • IFN-alpha induces rapid, time-, and dose-dependent tyrosine phosphorylation of CrkL.
  • Tyk-2 kinase is likely responsible for CrkL phosphorylation downstream of IFNR.
  • CrkL associates with C3G, activating Rap-1, a small G-protein with tumor suppressor activity.
  • IFN-beta and IFN-omega also induce CrkL phosphorylation, indicating a broader role in Type I IFN signaling.

Conclusions:

  • Tyrosine phosphorylation of CrkL is a critical step in Type I IFN signal transduction.
  • The CrkL-C3G-Rap-1 pathway mediates IFN-induced growth inhibition.
  • CrkL acts as a molecular link between the IFNR and cellular growth regulatory pathways.

More Related Videos

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF311:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: